INVO Fertility, Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INVO Fertility, Inc. stock issued during period, value, issued for services for the quarter ending 2026-06-30 was $24.26K, a 61.04% decline year-over-year.
- INVO Fertility, Inc. stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $70.92K.
- INVO Fertility, Inc. stock issued during period, value, issued for services for the quarter ending 2025-09-30 was $481.43K, a 1190.87% increase year-over-year.
- INVO Fertility, Inc. stock issued during period, value, issued for services for the quarter ending 2025-06-30 was $62.27K, a 3.78% increase year-over-year.
- INVO Fertility, Inc. stock issued during period, value, issued for services for fiscal 2025 was $1.31M, a 376.49% increase from fiscal 2024.
- INVO Fertility, Inc. stock issued during period, value, issued for services for fiscal 2024 was $275.75K, a 4.07% decline from fiscal 2023.
- INVO Fertility, Inc. stock issued during period, value, issued for services for fiscal 2023 was $287.45K, a 133.30% increase from fiscal 2022.
- INVO Fertility, Inc. stock issued during period, value, issued for services for fiscal 2022 was $123.21K, a 84.68% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-06-30 | $24.26K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $70.92K 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $1.31M 10-K · filed 2026-06-02 | |
| 2025-09-30 | $481.43K 10-Q · filed 2025-11-17 | |
| 2025-06-30 | $62.27K 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $275.75K 10-K · filed 2026-06-02 | |
| 2024-09-30 | $37.30K 10-Q · filed 2025-11-17 | $271.77K derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | $60.00K 10-Q · filed 2025-11-17 | $245.72K derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-03-31 | $142.45K 10-Q · filed 2025-11-17 | $280.00K derived: sum of 4 quarters · filed 2025-11-17 |
| 2023-12-31 | $32.03K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-30 | $287.45K 10-K · filed 2025-04-30 |
| 2023-09-30 | $11.25K 10-Q · filed 2024-11-19 | $261.87K derived: sum of 4 quarters · filed 2024-11-19 |
| 2023-06-30 | $94.28K 10-Q/A · filed 2024-11-19 | $250.62K derived: sum of 4 quarters · filed 2024-11-19 |
| 2023-03-31 | $149.90K 10-Q/A · filed 2024-11-19 | $206.26K derived: sum of 4 quarters · filed 2024-11-19 |
| 2022-12-31 | $6.45K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-19 | $123.21K 10-K/A · filed 2024-11-19 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $596.04K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $49.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $596.04K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $66.85K 10-Q · filed 2023-05-15 | $649.72K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $479.27K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $804.12K 10-K · filed 2023-04-17 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $395.41K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $103.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $414.91K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $221.25K 10-Q · filed 2022-05-16 | $334.11K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $70.56K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $150.86K 10-K · filed 2021-03-30 |
| 2020-09-30 | $19.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $85.30K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $22.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $80.80K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $38.00K 10-Q · filed 2021-05-17 | $58.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $46.60K 10-K · filed 2021-03-30 |
| 2019-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $126.80K derived: sum of 4 quarters · filed 2020-03-30 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $111.80K derived: sum of 4 quarters · filed 2020-03-30 |
| 2019-03-31 | $26.60K 10-Q · filed 2019-05-15 | $1.83M derived: sum of 4 quarters · filed 2020-03-30 |
| 2018-12-31 | $85.20K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $1.84M 10-K · filed 2020-03-30 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | |
| 2018-06-30 | $1.71M 10-Q · filed 2019-08-14 | |
| 2018-03-31 | $43.66K 10-K · filed 2020-03-30 | |
| 2017-12-31 | $215.13K 10-K · filed 2019-04-16 | |
| 2016-12-31 | $1.26M 10-K · filed 2018-03-29 | |
| 2014-12-31 | $118.30K 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |